FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and represents a method for producing a vaccine for brucellosis of vertebrates, involving cultivation of Brucella abortus brucellosis strain with subsequent cultivation on sterile nutrient medium with subsequent release of antigen in the form of bacterial mass and its conjugation with stabilizer containing sucrose and gelatine, sterilization, packing and lyophilisation, Brucella abortus strain Brucella abortus RB-51/SHCHBK is used as a brucellous strain of the genus Brucella abortus, and the bacterial mass of the strain Brucella abortus RB-51/SHCHBK with cell content of 1.0-4.0×1010 mc/cm3 is used as an antigen, with certain content of components, wherein pH of stabilizer is brought to 7.4-7.6 15-20% solution of caustic sodium, sterilizing it at 116-120°C for 20-30 minutes. Also, in a method for producing a vaccine against vertebral brucellosis, culturing a brucellous strain of the genus Brucella abortus with subsequent cultivation on sterile nutrient medium with subsequent release of antigen in form of bacterial mass and its conjugation with stabilizer containing sucrose and gelatin, sterilization, packing and lyophilisation, Brucella abortus Brucella abortus strain RB-51/SHCHBK is used as a brucellous strain, and the antigen is a bacterial mass of the strain Brucella abortus RB-51/SHCHBK with cell content of 1.0-4.0×1010 mc/cm3, wherein the stabilizer further contains beta-cyclodextrin, with a certain content of components, wherein the pH of the stabilizer is adjusted to 7.4-7.6 with 15-20% sodium hydroxide, sterilizing it at 116-120°C for 20-30 minutes.
EFFECT: invention allows to increase the target product storage life with preservation of its immunogenicity against vertebrate brucellosis.
2 cl, 6 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
WAY OF RECEPTION OF BRUCELLOUS ANTIGEN FROM STRAIN BRUCELLA ABORTUS 19 FOR MANUFACTURING OF UNIFORM BRUCELLOUS ANTIGEN FOR AA (AGGLUTINATION ASSAY), CFR (COMPLEMENT FIXATION REACTION) AND LCFR (LONG-TERM COMPLEMENT FIXATION REACTION), BRUCELLOUS ANTIGEN FOR ROSE BENGAL ASSAY (RBA) AND BRUCELLOUS ANTIGEN FOR RING TEST (RT) WITH MILK, WAY OF MANUFACTURING OF BRUCELLOUS DIAGNOSTIC SERUM AND DIAGNOSTIC SETS | 2008 |
|
RU2361610C1 |
METHOD FOR PREPARING CONCENTRATED BRUCELLA CELL CULTURE FROM Brucella abortus 19 STRAIN TO PREPARE BRUCELLOUS ANTIGENS, BRUCELLOUS ANTIGENS (THREE VERSIONS), METHOD OF MAKING BRUCELLOSIS DIAGNOSTIC SERUM AND TEST SYSTEM FOR DIAGNOSING BRUCELLOSIS IN ANIMALS (THREE VERSIONS) | 2014 |
|
RU2593712C2 |
VACCINE AGAINST BRUCELLOSIS IN CATTLE | 1997 |
|
RU2113857C1 |
VACCINE AGAINST CATTLE BRUCELLOSIS | 1997 |
|
RU2108110C1 |
METHOD OF OBTAINING OF BRUCELLOUS L-ANTIGEN | 2013 |
|
RU2539827C1 |
BRUCELLA ABORTUS UF-1 STRAIN FOR PREPARING BIOLOGICAL PREPARATIONS FOR DIAGNOSTICS AND SPECIFIC PREVENTION OF BRUCELLOSIS IN FARM ANIMALS | 2007 |
|
RU2425148C2 |
STRAIN BRUCELLA ABORTUS USED FOR PREPARING DIAGNOSTIC AND PROPHYLACTIC BIOPREPARATIONS AGAINST BRUCELLOSIS IN ANIMALS | 1997 |
|
RU2130068C1 |
STRAIN OF BACTERIUM BRUCELLA ABORTUS USED FOR PREPARING DIAGNOSTIC AND PROPHYLACTIC BIOPREPARATIONS AGAINST BRUCELLOSIS IN ANIMALS | 1999 |
|
RU2149183C1 |
BRUCELLOSIS VACCINE FOR FARM ANIMALS | 1992 |
|
RU2026081C1 |
METHOD TO PRODUCE BRUCELLOSIS ANTIGEN FOR ROSE BENGAL TEST (RBT) | 2011 |
|
RU2488119C2 |
Authors
Dates
2021-04-07—Published
2020-05-28—Filed